Trial Profile
An open-lab, multicenter, prospective, single-arm study for lower dose Decitabine in old subjects with intermediate-2 and high risk Myelodysplastic Syndrome (MDS)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 24 Sep 2014 New trial record